Up next

Autoplay

Improving TTD and supporting patient advocacy in CTCL

10 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Chalid Assaf, MD, PhD, Helios Klinikum Krefeld, Krefeld, Germany, highlights key areas of research in the field of cutaneous T-cell lymphoma (CTCL), in particular focusing on the need to reduce the time to diagnosis (TTD) and the importance of patient advocacy. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay